Bluepoint Invests in Eight Studio, Developer of Gait Analysis Medical Device, in Pre-Series A Round

Deep tech accelerator Bluepoint Partners announced on June 16 that it has made a pre-Series A investment in Eight Studio, an AI healthcare company specializing in gait analysis.

This investment was made through the 'InBodyLikeBluepoint' fund, which was established jointly with InBody. Dongmoon Partners and Magna Investment also participated. Bluepoint is discovering prospective and early-stage startups in the healthcare and lifestyle sectors through 'InBodyLike.' With this latest investment, Eight Studio's corporate value has more than doubled within one year since its seed funding.

Eight Studio is a company that develops the computer vision-based medical device 'MEDISTEP.' MEDISTEP is a markerless gait analysis solution that uses a mobile camera and, without any additional sensors, analyzes the entire body's joints to generate over 40 gait indicators within one minute. Compared to existing sensor-based motion measurement devices, it achieves more than 90% cost reduction and approximately 95% accuracy. It is being recognized for transforming the existing market with the new form factor of the mobile camera.

Within just one year of its launch, MEDISTEP has been adopted by eight major university hospitals in Korea, including Asan Medical Center in Seoul, and has secured initial clinical references. Its adoption is expanding to public health centers, welfare centers, and senior fitness centers nationwide, broadening its presence in both the public and private sectors.

Eight Studio plans to lay the groundwork for exports to five Asian countries this year by obtaining CE-MDR certification in Europe in the first half of the year. In addition, the company is preparing to enter global markets such as Japan and North America in collaboration with InBody. Eight Studio aims to strengthen its strategy to target the AI-based digital healthcare market by expanding its technology into areas such as sarcopenia and fall risk assessment.

Jungsoo Park, Principal at Bluepoint, said, "In the clinical gait analysis market, where there has been no standard-like measurement tool for identifying sarcopenia due to aging, we believe Eight Studio is a promising company with both verified accuracy and practical references from university hospitals and public health centers."

CEO Shinki Park stated, "In medical devices, usability—namely, user experience (UX)—is crucial. We will focus on enhancing productivity in medical settings by leveraging reliability and convenience as our strengths."

This content was produced with the assistance of AI translation services.